» Articles » PMID: 33309506

Neutrophil to Lymphocyte Ratio, Lymphocyte to Monocyte Ratio and Platelet to Lymphocyte Ratio to Predict the Severity of COVID-19

Overview
Journal Am J Emerg Med
Specialty Emergency Medicine
Date 2020 Dec 14
PMID 33309506
Citations 96
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: In this study, we aimed to investigate and compare the prognostic impacts of C-reactive protein (CRP), white blood cell (WBC) count, neutrophil (NEU)-to-lymphocyte (LYM) ratio (NLR), platelet-to-lymphocyte ratio (PLR), Red Cell Distribution Width (RDW) biomarkers in laboratory-confirmed COVID-19 cases as well as to explore the most useful diagnostic biomarkers and optimal cutoff values in COVID-19 patients.

Methods: A total of 233 patients were admitted to Emergency Department (ED) of Pamukkale University Hospital during two months (March-April 2020) and underwent Sars CoV-2 PCR (Polymerase Chain Reaction), complete blood count (CBC), and CRP tests in sequence due to complaints of COVID-19. The laboratory results and demographic findings were collected from the public health management system retrospectively. The patients with positive Sars CoV-2 PCR test along with hospitalization data were also recorded.

Results: The CRP (p = 0.0001), lactate dehydrogenase (LDH) (p = 0.038), PLR (p = 0.0001) and NLR (p = 0.001) remained significantly higher in the patients with positive Sars CoV-2 PCR test result. By contrast, eosinophil (p = 0.0001), lymphocyte (p = 0.0001), platelet levels (p = 0.0001) were calculated as significantly higher in negative Sars CoV-2 patients.

Conclusion: In the light of the obtained results, the CRP, LDH, PLR and NLR levels remained significantly higher in COVID-19 positive patients, while eosinophil, lymphocyte, and platelet levels were significantly elevated in COVID-19 negative patients.

Citing Articles

Evaluation of Novel Combined CBC-Derived Systemic Inflammatory Ratios and Their Dynamic Changes as ICU Mortality Predictors, a Retrospective Cohort.

Azmakan H, Hashemian F, Kazemian K Health Sci Rep. 2025; 8(3):e70441.

PMID: 40051492 PMC: 11882387. DOI: 10.1002/hsr2.70441.


A multicenter, real-world cohort study: effectiveness and safety of Azvudine in hospitalized COVID-19 patients with pre-existing diabetes.

Zhou Y, Yang Z, Zhang S, Zhang D, Luo H, Zhu D Front Endocrinol (Lausanne). 2025; 16:1467303.

PMID: 40046873 PMC: 11879813. DOI: 10.3389/fendo.2025.1467303.


Mechanical Ventilator-Associated Pneumonia in the COVID-19 Pandemic Era: A Critical Challenge in the Intensive Care Units.

Stoian M, Andone A, Bandila S, Onisor D, Laszlo S, Lupu G Antibiotics (Basel). 2025; 14(1.

PMID: 39858314 PMC: 11760855. DOI: 10.3390/antibiotics14010028.


Real-world effectiveness and safety of oral azvudine versus nirmatrelvir‒ritonavir (Paxlovid) in hospitalized patients with COVID-19: a multicenter, retrospective, cohort study.

Wang H, Cui G, Cheng M, Aji T, Li G, Hu X Signal Transduct Target Ther. 2025; 10(1):30.

PMID: 39819859 PMC: 11739574. DOI: 10.1038/s41392-025-02126-w.


Potential Correlation Between Hematological Parameters and Palpitation in Outpatients With COVID-19: A Retrospective Study.

Zhang L, Chen T, Wei L, Ren J, Gong J, Yuan H J Clin Lab Anal. 2025; 39(2):e25137.

PMID: 39810499 PMC: 11776496. DOI: 10.1002/jcla.25137.


References
1.
Lu J, Wei Z, Jiang H, Cheng L, Chen Q, Chen M . Lactate dehydrogenase is associated with 28-day mortality in patients with sepsis: a retrospective observational study. J Surg Res. 2018; 228:314-321. DOI: 10.1016/j.jss.2018.03.035. View

2.
Guo Y, Cao Q, Hong Z, Tan Y, Chen S, Jin H . The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status. Mil Med Res. 2020; 7(1):11. PMC: 7068984. DOI: 10.1186/s40779-020-00240-0. View

3.
Henry B, Aggarwal G, Wong J, Benoit S, Vikse J, Plebani M . Lactate dehydrogenase levels predict coronavirus disease 2019 (COVID-19) severity and mortality: A pooled analysis. Am J Emerg Med. 2020; 38(9):1722-1726. PMC: 7251362. DOI: 10.1016/j.ajem.2020.05.073. View

4.
Ding X, Yu Y, Lu B, Huo J, Chen M, Kang Y . Dynamic profile and clinical implications of hematological parameters in hospitalized patients with coronavirus disease 2019. Clin Chem Lab Med. 2020; 58(8):1365-1371. DOI: 10.1515/cclm-2020-0411. View

5.
Lu H, Stratton C, Tang Y . Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle. J Med Virol. 2020; 92(4):401-402. PMC: 7166628. DOI: 10.1002/jmv.25678. View